Eileen Goodwin

Health funding indecipherable

Health funding indecipherable

The funding formula used to hand out $9 billion of public money for health cannot be fully deciphered, a University of Otago technical report says.

Minister praises ED staff

Minister praises ED staff

Health Minister Tony Ryall surprised Dunedin Hospital emergency department staff with an impromptu visit yesterday.

Board to review radiology services

Radiology services are to be reviewed across Otago and Southland as the Southern District Health Board continues efforts to reduce waiting times for tests.

SDHB seeks dementia daycare provider

The Southern District Health Board is to seek a provider for a dementia daycare service, a report to today's disability and public health committee meeting in Dunedin says.

Health board projected deficit worsens

Health board projected deficit worsens

The Southern District Health Board's projected deficit has worsened to $10.2 million, a report to Thursday's board meeting says.

Bowel cancer 'at long last' getting the spotlight

Bowel cancer 'at long last' getting the spotlight

Bowel cancer is at long last getting the recognition it deserves, Southern District Health Board colorectal surgeon Associate Prof Mark Thompson-Fawcett says.

Ear, nose throat service overloaded

Some chronic nasal conditions will have to be treated by GPs because the Southern District Health Board's ear, nose, and throat department cannot cope with demand, service clinical leader Jamie Ryan says.

Call for bowel screening

Another 12,000 New Zealanders will have died from bowel cancer in the decade or so it could take to set up a national screening programme, Beat Bowel Cancer Aotearoa says.

Single chief medical position for Otago and Southland

The Southern District Health Board is introducing a single chief medical position, instead of chiefs in Otago and Southland, chief executive Carole Heatly has decided.

Researchers appealing to public for funds

Researchers appealing to public for funds

Dunedin researchers are appealing for the public to help fund stem cell research they say pharmaceutical companies will not touch.